The estimated Net Worth of Idec Incbiogen Idec Ma Inc ... is at least 15.5 百万$ dollars as of 27 September 2005. Idec Inc owns over 714,286 units of Sunesis Pharmaceuticals Inc stock worth over 15,491,957$ and over the last 19 years Idec sold SNSS stock worth over 0$.
Sign up
Idec Inc SNSS stock SEC Form 4 insiders trading
Idec has made over 1 trades of the Sunesis Pharmaceuticals Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Idec bought 714,286 units of SNSS stock worth 5,000,002$ on 27 September 2005.
The largest trade Idec's ever made was buying 714,286 units of Sunesis Pharmaceuticals Inc stock on 27 September 2005 worth over 5,000,002$. On average, Idec trades about 714,286 units every 0 days since 2005. As of 27 September 2005 Idec still owns at least 2,912,022 units of Sunesis Pharmaceuticals Inc stock.
You can see the complete history of Idec Inc stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Idec Inc's mailing address?
Idec's mailing address filed with the SEC is 14 CAMBRIDGE CENTER14 CAMBRIDGE CENTER, , CAMBRIDGECAMBRIDGE, MAMA, 0214202142.
Insiders trading at Sunesis Pharmaceuticals Inc
Over the last 19 years, insiders at Sunesis Pharmaceuticals Inc have traded over 89,557,714$ worth of Sunesis Pharmaceuticals Inc stock and bought 191,253,594 units worth 84,730,221$ . The most active insiders traders include Forest Baskett、Scott D Sandell、Peter J Barris. On average, Sunesis Pharmaceuticals Inc executives and independent directors trade stock every 67 days with the average trade being worth of 14,060,191$. The most recent stock trade was executed by Tina Gullotta on 29 May 2020, trading 6,000 units of SNSS stock currently worth 1,980$.
What does Sunesis Pharmaceuticals Inc's logo look like?
Complete history of Idec Inc stock trades at Sunesis Pharmaceuticals Inc
Sunesis Pharmaceuticals Inc executives and stock owners
Sunesis Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Adam Craig,
Executive Vice President - Development, Chief Medical Officer -
Stephen Ketchum,
Director -
David Stump,
Independent Director -
Homer Pearce,
Independent Director -
Nicole Onetto,
Independent Director -
Matthew Fust,
Independent Director -
Steve Carchedi,
Independent Director -
H. Ward Wolff,
Director -
Tina Gullotta,
Principal Accounting Officer, Vice President - Finance -
Dayton Misfeldt,
Chief Executive Officer, Principal Financial Officer, Secretary, Director -
James Young,
Non-Executive Independent Chairman of the Board -
Eric Bjerkholt,
EVP, CFO & Corp. Secretary -
Geoffrey M. Parker,
Director -
Steven B Ketchum,
Director -
Daniel N Jr Swisher,
President and CEO -
Oncology Impact Management ...,
-
William P. Quinn,
See Remarks -
Judith A. Fox,
See Remarks -
Patrick J Kerins,
10% owner -
Ryan D Drant,
10% owner -
Forest Baskett,
10% owner -
Peter J Barris,
10% owner -
M James Barrett,
10% owner -
Equity Opportunities Fund, ...,
-
City Capital Llc Bay City C...,
-
Scott D Sandell,
10% owner -
Krishna Kittu Kolluri,
10% owner -
Helen Susan Kim,
Director -
Joseph I De Pinto,
EVP, CCO -
Biopharma Partners Iii Lpal...,
-
Equity Opportunities Fund, ...,
-
Robert Scott Mc Dowell,
Vice President, Research -
Edward Hurwitz,
Director -
Dominique Semon,
10% owner -
Biopharma Partners Iii Lpal...,
-
Iii Eugene A Trainor,
10% owner -
Charles M Linehan,
10% owner -
Equity Opportunities Fund, ...,
-
Pincus Equity Partners Lpwa...,
-
Valerie L Pierce,
Sr. VP, GC & Corp. Secretary -
Anthony B Evnin,
Director -
Steven D Goldby,
Director -
James A Wells,
Director -
Stephen P A Fodor,
Director -
Idec Incbiogen Idec Ma Inc ...,
-
Pincus Equity Partners Lpwa...,
-
Daniel C Md Adelman,
Senior VP,Drug Discovery & Dev -
Ixmayfield Ix Management Ll...,
-
Jonathan S Leff,
Director -
Daryl B Winter,
SVP,Gen Counsel/Corp Secretary -
Capital Iv, Lp Aisling Capi...,